Pulmonary Nocardia concava infection in a patient with mantle cell lymphoma receiving bortezomib and rituximab

Lancet Infect Dis. 2022 Oct;22(10):1511. doi: 10.1016/S1473-3099(22)00344-9.
No abstract available

MeSH terms

  • Adult
  • Bortezomib / adverse effects
  • Humans
  • Lymphoma, Mantle-Cell* / complications
  • Lymphoma, Mantle-Cell* / drug therapy
  • Lymphoma, Mantle-Cell* / pathology
  • Nocardia Infections* / diagnosis
  • Nocardia Infections* / drug therapy
  • Nocardia*
  • Rituximab / adverse effects

Substances

  • Rituximab
  • Bortezomib

Supplementary concepts

  • Nocardia concava